“Wonderful staff (Carole is the best) and Dr Ledezma was wonderful. He spent a full hour talking to me and my family about my sickness, my prognosis and the planned procedure. I left having full confidence in him and in his staff. I wish every doctor would be so through !”
Thank you for the great review! We are very proud of our care team and when you are passionate about what you do, it is easy to provide great service.
We are pleased to announce the addition of Dr. Kristin Booth to our practice. She completed her fellowship in Women’s Imaging at Henry Ford Hospital in Detroit. In addition to general mammography and breast ultrasound, she has special interest in breast MRI and PET/CT. Dr. Booth will lead the continued development and growth of our women’s imaging division. If you would like to learn more about Dr. Booth or the procedures she provides, please contact us at 248-693-9295 or at McLaren Lapeer 810-667-5744.
Interventional oncology (IO) procedures provide minimally invasive, targeted treatments for cancer patients. IO procedures form an integral part of the multi-disciplinary team (i.e. medical oncology, surgical oncology, radiation oncology, and interventional oncology) approach in the treatment of cancer and cancer-related disorders.
Image guidance is used in combination with the most current innovations available to treat cancerous tumors, while minimizing possible injury to other body organs. Most patients having these procedures are outpatients or require a one night stay in the hospital.
- Some of these therapies are regional, as when treating cancers involving several areas of the liver with chemoembolization or radioembolization.
- Others are better classified as local, as when treating focal lesions in the kidney, liver, lung and bone with cryoablation (freezing), or microwave or radiofrequency ablation (heating).
In general, these techniques are reserved for patients whose cancer cannot be surgically removed or effectively treated with systemic chemotherapy. These procedures are also frequently used in combination with other therapies provided by other members of the cancer team.
Renal and Urology News (1/8, Charnow) reports that research published online in Cardiovascular and Interventional Radiology indicated that “computed tomography (CT)-guided percutaneous cryoablation for early-stage renal cell carcinoma (RCC) is highly efficacious and has a favorable safety profile.” Investigators came to this conclusion after treating “134 patients with biopsy-proven RCC using CT-guided cryotherapy.”
Dr. Ledezma, our Interventional Radiologist is active in diagnosing and treating patients with Renal Cell Carcinoma using CT-guided cryotherapy. If you are interested in being evaluated by Dr. Ledezma or have a patient that could benefit from it procedure, please contact him at 810-667-5744.